DCA Officials Seize ‘Colinol-Spas Tab’ For Misleading Claim

HYDERABAD: Officials of Drugs Control Administration, Telangana seized ‘Colinol-SPAS Tablets (Mefenamic Acid and Dicyclomine Hydrochloride Tablets IP)’, an allopathic medicine, in Nampally, Hyderabad, for making a misleading advertisement claiming it treats ‘disorders of menstrual flow’.

According to DCA Director-General VB Kamalasan Reddy here on Wednesday, the officials detected a medicine ‘Colinol-SPAS Tablets’ being circulating in the market with misleading claim on its label that it treats ‘disorders of menstrual flow’, which is a contravention of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 prohibits advertisement of certain drugs for treatment of certain diseases and disorders. No person shall take part in publication of advertisement regarding the diseases/disorders indicated under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

During the special raids conducted on 30th April and 1st May, officials from the Drugs Control Administration, Hyderabad Zone, detected ‘Colinol-SPAS Tablets’ (Mefenamic Acid and Dicyclomine Hydrochloride Tablets IP) Manufactured and Marketed by: Vivimed Labs Ltd., Plot No. 25, Kundeshwari Village, Kashipur- 244713, Uttarakhand. The label of the product bears a misleading claim stating that it is indicated for the treatment of ‘spasmodic dysmenorrhea, menstrual disorders.’

The advertisement of a medicine for the treatment of ‘disorders of menstrual flow’ is prohibited under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954. P. Santosh, Drugs Inspector, Mehdipatnam and V. Ajay, Drugs Inspector, Goshamahal are among the officers who carried out the raid. Further investigation shall be carried out and action shall be taken as per the law against all the offenders.

The public may report any complaints regarding illegal activities concerning medicines through the Drugs Control Administration, Telangana Toll-Free Number 1800-599-6969, which is operational from 10:30 am to 5:00 pm on all working days.

Related Posts

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

The report emphasizes that absolute R&D spending remains modest and identifies expanding investment in advanced biologics and AI-driven drug discovery as the “largest opportunity” for bridging the innovation divide. Recent…

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Early-stage activity drove the month, accounting for 73.6 per cent of total investments, while seed-stage rounds contributed the remaining 26.4 per cent. India’s pharma and healthcare funding for November 2025…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Novo Nordisk gears up for December Ozempic launch

Novo Nordisk gears up for December Ozempic launch

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit